학술논문

Infliximab therapy balances regulatory T cells, tumour necrosis factor receptor 2 (TNFR2) expression and soluble TNFR2 in sarcoidosis
Document Type
Article
Source
In: Clinical and Experimental Immunology. (Clinical and Experimental Immunology, 1 August 2016, 185(2):263-270)
Subject
Language
English
ISSN
13652249
00099104